Integral Health Asset Management’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-50,000
Closed -$3.66M 88
2025
Q1
$3.66M Buy
+50,000
New +$4.13M 0.39% 61
2024
Q3
Sell
-125,000
Closed -$8.56M 78
2024
Q2
$8.56M Buy
+125,000
New +$7.47M 0.81% 40
2022
Q2
Sell
-180,000
Closed -$13.3M 74
2022
Q1
$13.3M Hold
180,000
3.46% 4
2021
Q4
$13M Buy
180,000
+30,000
+20% +$2.18M 3.6% 7
2021
Q3
$11.5M Buy
150,000
+20,000
+15% +$1.61M 3.3% 6
2021
Q2
$10.1M Buy
130,000
+55,000
+73% +$3.91M 2.77% 8
2021
Q1
$4.63M Buy
75,000
+25,000
+50% +$1.58M 1.32% 31
2020
Q4
$3.26M Sell
50,000
-15,000
-23% -$862K 0.97% 37
2020
Q3
$3.22M Buy
+65,000
New +$3.35M 0.98% 36

Other funds holding GMED

Integral Health Asset Management's GMED Position: Q2 2025 in Review

Integral Health Asset Management sold out of Globus Medical (GMED) in Q2 2025, closing a stake of 50,000 shares — an estimated $3.66M sold.

Integral Health Asset Management first reported a position in GMED in Q3 2020 and held it in 9 quarters. The position peaked at $13.3M in Q1 2022. 480 funds tracked by Wall St. Rank hold GMED as of Q2 2025.

  • Integral Health Asset Management reported no remaining Globus Medical position as of Q2 2025 after selling out during the quarter.
  • Integral Health Asset Management sold 50,000 Globus Medical shares in Q2 2025, an estimated $3.66M.
  • Integral Health Asset Management first reported a position in Globus Medical in Q3 2020 and held it in 9 quarters.
  • Integral Health Asset Management's Globus Medical position peaked at $13.3M in Q1 2022.
  • 480 funds tracked by Wall St. Rank held Globus Medical as of Q2 2025.

Based on Integral Health Asset Management's 13F filing for Q2 2025, filed 14 Aug 2025.